相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival
Theresa J. Hydes et al.
CLINICAL THERAPEUTICS (2022)
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
Jennifer R. Kramer et al.
HEPATOLOGY (2022)
Metformin induces muscle atrophy by transcriptional regulation of myostatin via HDAC6 and FoxO3a
Min Ju Kang et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2022)
MAFLD: Renovation of clinical practice and disease awareness of fatty liver
Takumi Kawaguchi et al.
HEPATOLOGY RESEARCH (2022)
Lean/normal-weight metabolic dysfunction-associated fatty liver disease is a risk factor for reflux esophagitis
Shuhei Fukunaga et al.
HEPATOLOGY RESEARCH (2022)
Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus
Qiaomei Li et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)
Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis
Christine March et al.
CLINICAL NUTRITION ESPEN (2022)
Metabolic dysfunction-associated fatty liver disease directly related to liver fibrosis independent of insulin resistance, hyperlipidemia, and alcohol intake in morbidly obese patients
Susumu Inamine et al.
HEPATOLOGY RESEARCH (2022)
The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy
Bo Yuan et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies
Jin Chen et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2022)
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study
Luca Valenti et al.
HEPATOLOGY COMMUNICATIONS (2022)
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis
Eduardo Vilar-Gomez et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis
David E. Kaplan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis
Fausto Petrelli et al.
CANADIAN JOURNAL OF DIABETES (2021)
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis
Cori Campbell et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients
Wei-Ru Cho et al.
PLOS ONE (2021)
Diabetes Mellitus Increases the Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy: Systematic Review and Meta-Analysis
Szilard Vancsa et al.
FRONTIERS IN MEDICINE (2021)
Diabetes increases the risk of meningioma: A systematic review and meta-analysis of observational studies
Dongjie Shi et al.
CANCER EPIDEMIOLOGY (2021)
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
Tsubasa Tsutsumi et al.
HEPATOLOGY RESEARCH (2021)
High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection
Shingo Shimada et al.
HEPATOBILIARY SURGERY AND NUTRITION (2021)
Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review
Victor Cunha et al.
ANNALS OF HEPATOLOGY (2020)
Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis
Cui-Song Luo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2020)
Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes
Jian Zhou et al.
ANNALS OF HEPATOLOGY (2020)
Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest
Takuma Yamashita et al.
ANTI-CANCER DRUGS (2020)
Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis
Hiroki Yamana et al.
ANTICANCER RESEARCH (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Association between diabetes mellitus and lung cancer: Meta-analysis
Zi-Han Yi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Metformin Induces Autophagy via the AMPK-mTOR Signaling Pathway in Human Hepatocellular Carcinoma Cells
Chun Gao et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Risk Factors for Sarcopenia in the Elderly with Type 2 Diabetes Mellitus and the Effect of Metformin
Fenqin Chen et al.
JOURNAL OF DIABETES RESEARCH (2020)
Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma
Jun-Wen Hu et al.
JOURNAL OF CANCER (2020)
Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma
Lena Schulte et al.
LIVER INTERNATIONAL (2019)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes
Chin-Hsiao Tseng
LIVER INTERNATIONAL (2018)
Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats
Tian-Huei Chu et al.
CANCER MEDICINE (2018)
Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway
Sunbin Ling et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection
Kun-Ming Chan et al.
LIVER INTERNATIONAL (2017)
Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma
Taiga Chiyo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review
Anne-Claire Desbois et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies
Zhi-Feng Miao et al.
ONCOTARGET (2017)
Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway
Hsin-Hwa Tsai et al.
ONCOTARGET (2017)
mTOR Signaling in Growth, Metabolism, and Disease (vol 168, pg 960, 2017)
Robert A. Saxton et al.
CELL (2017)
The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin
Kiyohito Kato et al.
ONCOLOGY REPORTS (2016)
Metformin suppresses hypoxia-induced stabilization of HIF-1′ through reprogramming of oxygen metabolism in hepatocellular carcinoma
Xinke Zhou et al.
ONCOTARGET (2016)
Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection A Nationwide Population-Based Study
Young-Seok Seo et al.
MEDICINE (2016)
The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
Younak Choi et al.
CANCER RESEARCH AND TREATMENT (2016)
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib
Andrea Casadei Gardini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo
Shintaro Fujihara et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma
Hamza Chettouh et al.
LIVER INTERNATIONAL (2015)
Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies
Takayuki Fujimori et al.
ONCOLOGY REPORTS (2015)
Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases
Cristina Bosetti et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell
Gang Han et al.
CANCER BIOLOGY & THERAPY (2015)
Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes-National cohort of Taiwan Diabetes Study
Chia-Ing Li et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
Hisaaki Miyoshi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Diabetes Mellitus and Poorer Prognosis in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Yan-Gang Wang et al.
PLOS ONE (2014)
Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
Monica Enguita-German et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
S. Schlesinger et al.
ANNALS OF ONCOLOGY (2013)
Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study
W-P Koh et al.
BRITISH JOURNAL OF CANCER (2013)
Antitumor effect of metformin in esophageal cancer: In vitro study
Mitsuyoshi Kobayashi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Ana Chocarro-Calvo et al.
MOLECULAR CELL (2013)
Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
Bindiya Thakkar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
Motoi Hashiba et al.
PLOS ONE (2013)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
Hui Zhang et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Shih-Wei Lai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
Ping Wang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
Chenggang Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
Jin Ha Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Prognostic Influence of Metformin as First-Line Chemotherapy for Advanced Nonsmall Cell Lung Cancer in Patients With Type 2 Diabetes
Ben-Xu Tan et al.
CANCER (2011)
Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer
Y. Baba et al.
BRITISH JOURNAL OF CANCER (2010)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
Valter Donadon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Insulin, insulin-like growth factors and neoplasia
Michael Pollak
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan
Chi-Ling Chen et al.
GASTROENTEROLOGY (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis c-related cirrhosis
Joel R. Pekow et al.
CANCER (2007)
Diabetes mellitus and the risk of cancer - Results from a large-scale population-based cohort study in Japan
Manami Inoue et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
JA Davila et al.
GUT (2005)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
K Ohata et al.
CANCER (2003)
Hyperinsulinemia predicts fetal liver cancer but is inversely associated with fatal cancer at some other sites -: The Paris Prospective Study
B Balkau et al.
DIABETES CARE (2001)
A prospective study of obesity and cancer risk (Sweden)
A Wolk et al.
CANCER CAUSES & CONTROL (2001)
分享论文
